Showing results (711-720 of 968) with videos related to

Sort By:
Pageof 97
Annals of Surgical Oncology|January 3, 2021
Inaccurate Clinical Stage Is Common for Gastric Adenocarcinoma and Is Associated with Undertreatment and Worse OutcomesMichelle R Ju, John D Karalis, James-Michael Blackwell, et al.
The Journal of Nutrition|September 6, 2021
Systematic Review of the Effects of Oat Intake on Gastrointestinal HealthEzra Valido, Jivko Stoyanov, Alessandro Bertolo, et al.
Vox Sanguinis|May 26, 2010
Reduced risk of transfusion-transmitted HIV in Kenya through centrally co-ordinated blood centres, stringent donor selection and effective p24 antigen-HIV antibody screeningS V Basavaraju, J Mwangi, J Nyamongo, et al.
JAMA Surgery|February 22, 2013
Comparative effectiveness of minimally invasive and open distal pancreatectomy for ductal adenocarcinomaDeepa Magge, William Gooding, Haroon Choudry, et al.
Gut|August 21, 2020
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancerJin Huang, Pan Chen, Ke Liu, et al.
Surgical Endoscopy|March 15, 2024
The development of a deep learning model for automated segmentation of the robotic pancreaticojejunostomyAmr I Al Abbas, Babak Namazi, Imad Radi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2026
Correlates of Dolutegravir Resistance in Low- and Middle-Income Countries: A Combined Analysis of Drug Resistance Surveys in Four CountriesJuliana da Silva, Mariama Tejan, Sherri Pals, et al.
AIDS Research and Human Retroviruses|January 25, 2005
Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infectionsClement Zeh, Danuta Pieniazek, Simon M Agwale, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2015
The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesotheliomaAatur D Singhi, Alyssa M Krasinskas, Haroon A Choudry, et al.
Clinical Colorectal Cancer|August 24, 2011
A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancerRajesh Sehgal, Barry C Lembersky, Kiran K Rajasenan, et al.
Pageof 97